Low rate of recurrent bleeding after double-balloon endoscopy-guided therapy in patients with overt obscure gastrointestinal bleeding
- PMID: 32382887
- DOI: 10.1007/s00464-020-07615-3
Low rate of recurrent bleeding after double-balloon endoscopy-guided therapy in patients with overt obscure gastrointestinal bleeding
Abstract
Background: Double-balloon endoscopy (DBE) provides both diagnosis and treatment in overt obscure gastrointestinal bleeding (OGIB). The aim of this study was to evaluate the rebleeding rate after DBE.
Methods: This retrospective review was conducted between January 2006 and July 2018, 166 patients with overt OGIB who underwent DBE were enrolled. Therapeutic intervention was defined as endoscopic treatment, embolization, or surgery. Primary outcome was rebleeding rate after DBE. The patients were divided into 3 groups based on their DBE; (1) positive DBE requiring therapeutic intervention (G1), (2) positive DBE without therapeutic intervention required (G2) and (3) negative DBE (G3). Cumulative incidence of rebleeding was estimated using the Kaplan-Meier method. Cox regression was used to assess the association of DBE with rebleeding risk. This study was approved by our Institutional Review Board.
Results: Sixty-eight patients (41%) were categorized in G1, 34 patients (20%) in G2 and 64 patients (39%) in G3. Overall rebleeding occurred in 24 patients (15%). The cumulative incidence of rebleeding for G1 was the lowest. The 1-year and 2-year cumulative probability of developing rebleeding after DBE in G1 were 3.5% and 3.5%, 8.2% and 14.0% in G2, and 18.2% and 20.6% in G3, respectively (p = 0.02). After adjusting for bleeding severity and comorbidities, patients with positive DBE requiring therapeutic intervention had a significantly lower rate of rebleeding when compared with patients who did not receive intervention (hazard ratio 0.17; 95% CI 0.03-0.90).
Conclusion: DBE-guided therapeutic intervention was associated with a lower risk of rebleeding when compared with those with negative and positive DBE without therapeutic intervention. One-fifth of patients with overt OGIB had false negative after DBE.
Keywords: Endoscopy; Obscure gastrointestinal bleeding; Outcome; Small bowel bleeding.
Similar articles
-
Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?Dig Endosc. 2015 Mar;27(3):338-44. doi: 10.1111/den.12384. Epub 2014 Nov 3. Dig Endosc. 2015. PMID: 25251991
-
Long-term follow-up of patients undergoing capsule and double-balloon enteroscopy for identification and treatment of small-bowel vascular lesions: a prospective, multicenter study.Endoscopy. 2014 Jul;46(7):591-7. doi: 10.1055/s-0034-1365514. Epub 2014 May 15. Endoscopy. 2014. PMID: 24830401 Clinical Trial.
-
Long-Term Outcomes in Patients with Overt Obscure Gastrointestinal Bleeding After Negative Double-Balloon Endoscopy.Dig Dis Sci. 2015 Dec;60(12):3691-6. doi: 10.1007/s10620-015-3792-8. Epub 2015 Jul 15. Dig Dis Sci. 2015. PMID: 26173504
-
Clinical Utility of Capsule Endoscopy and Double-Balloon Enteroscopy in the Management of Obscure Gastrointestinal Bleeding.Digestion. 2018;97(1):52-58. doi: 10.1159/000484218. Epub 2018 Feb 1. Digestion. 2018. PMID: 29393257 Review.
-
Combined use of capsule endoscopy and double-balloon enteroscopy in the diagnosis of obscure gastrointestinal bleeding: meta-analysis and pooled analysis.Hepatogastroenterology. 2013 Nov-Dec;60(128):1885-91. Hepatogastroenterology. 2013. PMID: 24719922 Review.
Cited by
-
Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy.Endosc Int Open. 2021 Aug 23;9(9):E1397-E1403. doi: 10.1055/a-1499-6988. eCollection 2021 Sep. Endosc Int Open. 2021. PMID: 34466365 Free PMC article.
-
A newly developed deep learning-based system for automatic detection and classification of small bowel lesions during double-balloon enteroscopy examination.BMC Gastroenterol. 2024 Jan 2;24(1):10. doi: 10.1186/s12876-023-03067-w. BMC Gastroenterol. 2024. PMID: 38166722 Free PMC article.
References
-
- ASGE Standards of Practice Committee, Fisher L, Lee Krinsky M, Anderson MA, Appalaneni V, Banerjee S, Ben-Menachem T, Cash BD, Decker GA, Fanelli RD, Friis C, Fukami N, Harrison ME, Ikenberry SO, Jain R, Jue T, Khan K, Maple JT, Strohmeyer L, Sharaf R, Dominitz JA (2010) The role of endoscopy in the management of obscure GI bleeding. Gastrointest Endosc 72:471–479 - DOI
-
- Gerson LB, Fidler JL, Cave DR, Leighton JA (2015) ACG Clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol 110:1265–1287 (quiz 1288) - DOI
-
- Shinozaki S, Yamamoto H, Yano T, Sunada K, Miyata T, Hayashi Y, Arashiro M, Sugano K (2010) Long-term outcome of patients with obscure gastrointestinal bleeding investigated by double-balloon endoscopy. Clin Gastroenterol Hepatol 8:151–158 - DOI
-
- Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, Rossini FP, De Franchis R (2004) Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology 126:643–653 - DOI
-
- Gerson LB, Batenic MA, Newsom SL, Ross A, Semrad CE (2009) Long-term outcomes after double-balloon enteroscopy for obscure gastrointestinal bleeding. Clin Gastroenterol Hepatol 7:664–669 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical